Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
Monitoring brain inflammation and immune cell trafficking of the brain are essential to the study of pathogen clearance from the central nervous system. Brain monitoring is a technology which contains the application of different devices to monitor the structure, function or pharmacology of the brain such as electrical activity, blood flow & magnetic activity, pressure surrounding the brain, cerebral oxygen, saturation & anomalies such as tumors or infections. Furthermore, in Europe it has been estimated that 35% of all disease burden is attributable to brain disorders. Moreover, Traumatic brain injury (TBI) is a major global public health problem, which recorded around 1.7 million cases annually in the USA, corresponding to approximately 0.5% of the country's population. Additionally, worldwide about 5.48 million people are estimated to suffer from severe TBI each year. However, the brain related diseases are very complicated and treatment cost are too high. Currently, there are numerous types of brain monitoring devices available that combat these diseases.
Rising healthcare expenditure, technological advancements in brain monitoring devices, increasing Incidence and prevalence of neurological disorders are some major factors driving the growth of the brain monitoring devices market. Additionally, growing Incidence of traumatic brain injuries and increasing disorders due to lifestyle changes has also impacted the growth of the brain monitoring devices market globally. On the other hand, factors such as unfavourable reimbursement policies and high cost of complex brain monitoring devices & procedures are hampering the growth of the market. Whereas, increasing clinical trials applications and rising demand for non-invasive and minimally invasive devices are some factors creating opportunities in brain monitoring devices market.
The brain monitoring devices market is segmented by technology, procedure, disease type, end user and geography.
Based on technology, the brain monitoring devices market is segmented into magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, intracranial pressure monitors, electroencephalography devices, cerebral oximeters, trans-cranial doppler sonography, magnetoencephalography (MEG) and electromyography devices. Among these, the electroencephalography devices segment dominated the market in 2018, owing to the growing number of people suffering from neurological diseases.
On the basis of procedure, the brain monitoring devices market is segmented into noninvasive devices and invasive devices. The noninvasive devices dominated the global market in 2018. The noninvasive brain monitoring procedures are in high demand because these are much quicker, easier and more economical than invasive procedures. It is expected that the noninvasive segment will continue its dominance during the forecast period.
The various disease types of the brain monitoring devices market are covered in the report such as traumatic brain injuries, stroke, dementia, headache disorders, sleep disorders (sleep monitoring devices), epilepsy, Parkinson’s disease and Huntington’s disease. Traumatic brain injury usually results from a violent blow to the head or body. An object that penetrates brain tissue, such as a bullet or shattered piece of skull, also can cause traumatic brain injury. Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Memory loss is an example. Alzheimer's is the most common type of dementia.
Based on end user, the brain monitoring devices market is segmented into hospitals, neurology centers, clinics & ambulatory surgical centers and diagnostic centers. Among these, the hospitals segment dominated the brain monitoring devices market in 2018, because hospitals are highly preferred by patients over other healthcare centers since they provide treatment, diagnosis, and surgical intervention for various disorders.
Brain Monitoring Devices Market by Geography The brain monitoring devices market report is studied across the key countries of North America, Europe, Asia Pacific and Rest of the World. North America dominates the market for brain monitoring, accounting for the highest market value in 2018, owing to the presence of the strong distribution and sales network of the neurodiagnostic companies, government initiatives to support technological advancement and availability of the insurance coverage for the techniques of the brain monitoring. Whereas, Asia Pacific is expected to witness the fastest growth rate during the forecast period.
Some key players of this market includes Compumedics Limited, GE Healthcare, Medtronic PLC, Natus Medical, Nihon Kohden Corporation, Philips Healthcare and Siemens Healthineers (A Division of Siemens Ag). Among others are Electrical Geodesics, Inc., CAS Medical Systems, Inc, Advanced Brain Monitoring, Inc., Virtual Expo group, Braintronics, Masimo, Aspect Medical Systems, Inc., Cortech solutions, Inc., Integra LifeSciences Corporation, NeuroPace and Alliance Biomedica. New product launches, research and development and mergers & acquisitions are the key strategies adopted by market players to ensure their growth in the market.
The brain monitoring devices market is segmented by technology, procedure, disease type, end user and geography. Based on technology, the brain monitoring devices market is segmented into magnetic resonance imaging (MRI) devices, computerized tomography (CT) devices, positron emission tomography (PET) devices, intracranial pressure monitors, electroencephalography devices, cerebral oximeters, trans-cranial doppler sonography, magnetoencephalography (MEG) and electromyography devices. Among these, the electroencephalography devices segment dominated the market in 2018. On the basis of procedure, the brain monitoring devices market is segmented into noninvasive devices and invasive devices. The noninvasive devices dominated the global market in 2018. The noninvasive brain monitoring procedures are in high demand because these are much quicker, easier and more economical than invasive procedures. The various disease types of the brain monitoring devices market are covered in the report such as traumatic brain injuries, stroke, dementia, headache disorders, sleep disorders (sleep monitoring devices), epilepsy, Parkinson’s disease and Huntington’s disease. Traumatic brain injury usually results from a violent blow to the head or body. An object that penetrates brain tissue, such as a bullet or shattered piece of skull, also can cause traumatic brain injury. Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Memory loss is an example. Alzheimer's is the most common type of dementia. The major end users of the market includes hospitals, neurology centers, clinics & ambulatory surgical centers and diagnostic centers.Among these, the hospitals segment dominated the brain monitoring devices market in 2018. Based on geography, the brain monitoring devices market is segmented into North America, Europe, Asia-Pacific and rest of the world. North America dominates the market for brain monitoring, accounting for the highest market value in 2018, owing to the presence of the strong distribution and sales network of the neurodiagnostic companies, government initiatives to support technological advancement and availability of the insurance coverage for the techniques of the brain monitoring.
Why to buy this report:
